Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Effects of potent antiretroviral therapy on the immune activation marker soluble CD27 in patients infected with HIV-1 subtypes A-D.

Journal of medical virology - 1 Mar 2004

Atlas Ann, Thanh Ha Tran Thi, Lindström Anna, Nilsson Anna, Alaeus Annette, Chiodi Francesca, De Milito Angelo

Abstract excerpt

HIV-1 genetic subtypes might have a different impact on disease progression and response to antiretroviral therapy (ART). Few data are available on the immune activation profile in patients with different HIV-1 subtypes. We have tested by ELISA the plasma levels of an immune activation marker, soluble CD27 (sCD27), in a cohort of 64 patients infected with HIV-1 subtypes A-D, at baseline and after 1 year of...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Anti-HIV Agents
Share to Antiretroviral Therapy, Highly Active

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to Biomarkers

Share to HIV Infections

Share to Longitudinal Studies

Share to Tumor Necrosis Factor Receptor Superfamily, Member 7

Share to Viral Load

Source

Identifiers

PMID: 14748056
DOI: 10.1002/jmv.20006

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence. Graph snapshot: 2026-09-29.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Effects of potent antiretroviral therapy on the immune activation marker soluble CD27 in patients infected with HIV-1 subtypes A-D.PMID 14748056Read ↗

High CD8+ T cell activation marks a less differentiated HIV-1 specific CD8+ T cell response that is not altered by suppression of viral replication.Semantic proximity Read ↗

One of the immune activation profiles observed in HIV-1-infected adults with suppressed viremia is linked to metabolic syndrome: The ACTIVIH studySemantic proximity Read ↗

Altered T cell differentiation associated with loss of CD27 and CD28 in HIV infected Indian individualsSemantic proximity Read ↗

Antigen Presenting Cells Contribute to Persistent Immune Activation Despite Antiretroviral Therapy Initiation During Hyperacute HIV-1 Infection.Semantic proximity Read ↗

Low-Level CD4+ T Cell Activation Is Associated with Low Susceptibility to HIV-1 InfectionSemantic proximity Read ↗

Positive Effects of Combined Antiretroviral Therapy on CD4 <sup>+</sup> T Cell Homeostasis and Function in Advanced HIV DiseaseSemantic proximity Read ↗

Altered lymphocyte antigen expressions in HIV infection: a study by quantitative flow cytometry.Semantic proximity Read ↗

Association of HIV clinical disease progression with profiles of early immune activationSemantic proximity Read ↗

Progression of HIV to AIDS: a protective role for HLA-B27?Semantic proximity Read ↗

Normal or even increased dendritic cell and peripheral blood lymphocyte subsets with regulatory phenotype in clinically stable long-term HIV-infected patients with hemophilia on highly active antiretroviral therapy.Semantic proximity Read ↗

CD38+CD8+ and CD38+CD4+ T Cells and IFN Gamma (+874) Polymorphism Are Associated with a Poor Virological Outcome.Semantic proximity Read ↗

Effect of HIV type 1 subtype on virological and immunological response to combination antiretroviral therapy: evidence for a more rapid viral suppression for subtype A than subtype B-infected Greek individuals.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.